Do your own DD and you'll find that prostate cancer results will be released any day now. It's an easy double to $4 in the short term and $15 by the end of the year IMO. The pain of LNKD losses will soon be forgotten.
Until NYMX is over $5. For now I will remain patient and excited about this company's future regardless of where it may trade in the short term. If you need a reminder of how sound your investment is in NYMX you can always reflect on the Y! Finance insider transaction report: Robinson bought $1,287,864 worth of shares after Nov 30th, 2015. He has now spent over $6,300,000 at an approximate $2.4 cost per share. He hasn't sold any and continues to buy more this year. I expect to be posting again before the end of the month...GLTA